Definitive Contract HHSF223201210196C

This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the Massachusetts Department of Public Health, a U.S. state government entity, for Mass MQSA (Mammography Quality Standards Act) inspections. The contract has a firm fixed price pricing type and a potential value of $1,711,136.29. It was awarded on June 1, 2017 with a completion date of June 30, 2022. This contract is not associated with a larger vehicle and does not have a...

The U.S. Food and Drug Administration (FDA) awarded a $2,482,950.23 Firm Fixed Price contract to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency, to implement the Mammography Quality Standards Act (MQSA). The contract, awarded without any set-aside designation, runs through March 2022 and requires MDLEO to provide specialized regulatory oversight and services to ensure the quality and safety of mammography facilities. As a state...

The Food and Drug Administration (FDA) awarded a $236,714.59, firm fixed price definitive contract to the New Hampshire Department of Health and Human Services (NH DHHS) to perform inspections of certified non-federal mammography facilities in New Hampshire. This contract, which runs through March 31, 2028, is to ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract was not set aside and was competitively awarded to the state agency, which...

<p>The U.S. Food and Drug Administration (FDA) awarded a $359,633.67 firm fixed price definitive contract to the Alaska Division of Public Health for ALASKA MQSA STATE INSPECTIONS. The contract has an ultimate completion date of March 4, 2028. There is no set-aside designation for this award. The contract requires the Alaska Division of Public Health to provide MQSA state inspections services in Anchorage, Alaska.</p>

This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...

This is a $501,949.66 firm fixed price contract awarded by the Food and Drug Administration (FDA) to the Rhode Island Department of Health to conduct inspections of mammography facilities in Rhode Island under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of January 14, 2028. The Rhode Island Department of Health, a U.S. state government entity, will be the prime contractor delivering these inspection services. This contract award is not associated...

The Food and Drug Administration awarded a firm fixed price definitive contract valued at one million one hundred thirty thousand fifteen dollars and eighty-one cents ($1,130,015.81) to the Florida Department of Health for MQSA inspections. The place of performance is Tallahassee, Florida. No set-aside designation was used for this contract. As the designated state health agency for Florida, the Department of Health will utilize its resources across the state to conduct Mammography Quality...

This is a $1,147,389.43 firm-fixed-price federal contract awarded by the Food and Drug Administration (FDA) to the Health Services Kentucky Cabinet For, a U.S. state government entity. The contract is for the Kentucky MQSA Inspection Contract, which involves conducting inspections of certified non-federal mammography facilities in Kentucky to ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The original solicitation indicated this is a sole-source...

This is a definitive contract awarded by the U.S. Food and Drug Administration (FDA) to The Environment Maryland Department Of Office Of Fiscal Services Division, doing business as State Of Maryland, for $705,383.99. The contract is for Mammography Quality Standards Act (MQSA) inspections and does not have a set-aside designation. As the state environmental protection agency, The Environment Maryland Department is responsible for various environmental programs, monitoring activities, and...

This is a Definitive Contract awarded by the Food and Drug Administration (FDA) to the New Mexico Environment Department (NMED) for $650,130.35 to provide Mammography Quality Standards Act (MQSA) inspections in New Mexico. The contract is a Firm Fixed Price agreement with a period of performance through January 14, 2028. NMED, a state government agency, has extensive experience conducting regulatory inspections and environmental monitoring services for federal agencies. This contract award,...